Moderators: Christoph P. Hofstetter, MD, PhD and Karthik Madhavan, MD
Spinal Cord Injury (SCI) leads to cellular destruction of from primary injury at the time of insult followed by secondary injury from release of cascade of chemical reactions. This is of interest for researchers as it can be modified or modulated. Over 250,000 patients in United States are being evaluated for different SCI.
In this symposium, we present latest advances in basic science research both in acute and chronic SCI. We will discuss the pros and cons of some of latest topics and publications. This will abreast the clinicians and researchers alike and also provide opportunities to discuss some of the research they are working on and enrolling in new SCI trials.
Upon completion of this session, participants should gain strategies to:
- Appraise their knowledge about latest nuances on acute spinal cord injury;
- Latest interventions being evaluated in lab SCI modules;
- Discuss the enrolling in new SCI;
- Discussion of participant generated research questions;
- Overview of new developments in SCI research.
Agenda
Biomarkers of Acute SCI & Translational Perspectives
Brian Kwon, MD, PhD
Inflammation in SCI
Walter Jermakowicz, MD, PhD
KCC2 Manipulations
Yi Lu, MD, PhD
Scaffold Implantation
Christoph P. Hofstetter, MD, PhD
Q & A with Discussion on Participant-Generated Research
Faculty